Genital and anorectal mucosal melanoma is associated with cutaneous melanoma in patients and in families

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 594-599

  Cazenave, H ^a   Maubec, E ^a   Mohamdi, H ^b,c   Grange, F ^d,e   Bressac De Paillerets, B ^b   Demenais, F ^b   Avril, M F ^f,g  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f Institut Cochin   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; ANORECTAL DISEASE; ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENITAL AND ANORECTAL MUCOSAL MELANOMA; GENITAL SYSTEM DISEASE; HAIR COLOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NEVUS; PHENOTYPE; PIGMENTATION; PRIORITY JOURNAL; RISK FACTOR; SKIN COLOR; SUN EXPOSURE;

ANUS NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GERM-LINE MUTATION; HUMANS; INTESTINAL MUCOSA; MALE; MELANOMA; MIDDLE AGED; NEVUS; PEDIGREE; PHENOTYPE; PIGMENTATION DISORDERS; RECTAL NEOPLASMS; SKIN NEOPLASMS;

EID: 84883430280     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12421     Document Type: Article

References (48)

1. Chang AE, Karnell LH, Menck HR,. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664-78.
2. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41: 28-44.
3. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
4. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-59.
5. Bishop DT, Demenais F, Goldstein AM, et al,. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94: 894-903.
6. Kamb A, Shattuck-Eidens D, Eeles R, et al,. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994; 8: 23-6.
7. Hussussian CJ, Struewing JP, Goldstein AM, et al,. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15-21.
8. Zuo L, Weger J, Yang Q, et al,. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996; 12: 97-9.
9. Meyle KD, Guldberg P,. Genetic risk factors for melanoma. Hum Genet 2009; 126: 499-510.
10. Bertolotto C, Lesueur F, Giuliano S, et al,. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011; 480: 94-8.
11. Law MH, Macgregor S, Hayward NK,. Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol 2012; 132: 1763-74.
12. Hu DN, Yu GP, McCormick SA,. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res 2010; 20: 153-8.
13. Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlof B, et al,. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer 1999; 86: 1273-84.
14. Curtin JA, Fridlyand J, Kageshita T, et al,. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-47.
15. Curtin JA, Busam K, Pinkel D, Bastian BC,. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-6.
16. Omholt K, Grafstrom E, Kanter-Lewensohn L, et al,. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 2011; 17: 3933-42.
17. Chaudru V, Chompret A,. Bressac-de Paillerets B et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 2004; 96: 785-95.
18. Grange F, Chompret A, Guilloud-Bataille M, et al,. Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 1995; 131: 1154-9.
19. Bataille V, Bishop JA, Sasieni P, et al,. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605-11.
20. McLaughlin CC, Wu XC, Jemal A, et al,. Incidence of noncutaneous melanomas in the U.S. Cancer 2005; 103: 1000-7.
21. Koomen ER, de Vries E, van Kempen LC, et al,. Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev 2010; 19: 1453-9.
22. Cote TR, Sobin LH,. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin. Melanoma Res 2009; 19: 58-60.
23. Sugiyama VE, Chan JK, Shin JY, et al,. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007; 110: 296-301.
24. de Giorgi V, Gori A, Alfaioli B, et al,. Influence of sex hormones on melanoma. J Clin Oncol 2011; 29: e94-5; author reply e96.
25. Scott MC, Suzuki I, Abdel-Malek ZA,. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res 2002; 15: 433-9.
26. Gandini S, Iodice S, Koomen E, et al,. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer 2011; 47: 2607-17.
27. Lotem M, Anteby S, Peretz T, et al,. Mucosal melanoma of the female genital tract is a multifocal disorder. Gynecol Oncol 2003; 88: 45-50.
28. Weinstock MA,. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994; 171: 1225-30.
29. Newton-Bishop JA, Chang YM, Elliott F, et al,. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 2011; 47: 732-41.
30. Landi MT, Baccarelli A, Calista D, et al,. Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 2001; 85: 1304-10.
31. Nagore E, Botella-Estrada R, Garcia-Casado Z, et al,. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain. J Eur Acad Dermatol Venereol 2008; 22: 931-6.
32. Miller BJ, Rutherford LF, McLeod GR, Cohen JR,. Where the sun never shines: anorectal melanoma. Aust N Z J Surg 1997; 67: 846-8.
33. Ragnarsson-Olding BK, Nilsson PJ, Olding LB, Nilsson BR,. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years. Acta Oncol 2009; 48: 125-31.
34. Moan J, Porojnicu AC, Dahlback A, et al,. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B 2010; 101: 179-83.
35. Ragnarsson-Olding BK,. Primary malignant melanoma of the vulva-an aggressive tumor for modeling the genesis of non-UV light-associated melanomas. Acta Oncol 2004; 43: 421-35.
36. Micu E, Juzeniene A, Moan J,. Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway. J Eur Acad Dermatol Venereol 2011; 25: 1444-9.
37. Weinstock MA,. Epidemiology and prognosis of anorectal melanoma. Gastroenterology 1993; 104: 174-8.
38. Cicarma E, Juzeniene A, Porojnicu AC, et al,. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol B 2010; 101: 174-8.
39. Stierner U, Rosdahl I, Augustsson A, Kagedal B,. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. J Invest Dermatol 1989; 92: 561-4.
40. Ullrich SE, Byrne SN,. The immunologic revolution: photoimmunology. J Invest Dermatol 2012; 132: 896-905.
41. De Simone P, Silipo V, Buccini P, et al,. Vulvar melanoma: a report of 10 cases and review of the literature. Melanoma Res 2008; 18: 127-33.
42. Wechter ME, Gruber SB, Haefner HK, et al,. Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol 2004; 50: 554-62.
43. Rohwedder A, Slominski A, Wolff M, et al,. Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol 2007; 29: 13-17.
44. Takamiyagi A, Asato T, Nakashima Y, Nonaka S,. Association of human papillomavirus type 16 with malignant melanoma. Am J Dermatopathol 1998; 20: 69-73.
45. Cagir B, Whiteford MH, Topham A, et al,. Changing epidemiology of anorectal melanoma. Dis Colon Rectum 1999; 42: 1203-8.
46. Dahlgren L, Schedvins K, Kanter-Lewensohn L, et al,. Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes. Acta Oncol 2005; 44: 694-9.
47. Lundberg R, Brytting M, Dahlgren L, et al,. Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes. Anticancer Res 2006; 26: 3627-31.
48. Giraud G, Ramqvist T, Ragnarsson-Olding B, Dalianis T,. DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol 2008; 46: 3595-8.